BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1624542)

  • 1. A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
    Teicher BA; Holden SA; Ara G; Ha CS; Herman TS; Northey D
    J Cancer Res Clin Oncol; 1992; 118(7):509-14. PubMed ID: 1624542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement by perflusion emulsion (Oxygent) and carbogen breathing of the tumor growth delay of the FSaIIC fibrosarcoma after treatment with antitumor alkylating agents.
    Holden SA; Teicher BA; Ha C; Ara G; Herman TS
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):895-8. PubMed ID: 1391529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.
    Teicher BA; Herman TS; Hopkins RE; Menon K
    J Cancer Res Clin Oncol; 1992; 118(2):123-8. PubMed ID: 1735732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA; Holden SA; Jacobs JL
    Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
    Teicher BA; Herman TS; Tanaka J; Dezube B; Pardee A; Frei E
    Cancer Chemother Pharmacol; 1991; 28(1):45-50. PubMed ID: 1904012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
    Teicher BA; Bernal SD; Holden SA; Cathcart KN
    Cancer Chemother Pharmacol; 1988; 21(4):281-5. PubMed ID: 3131032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of various oxygenation conditions and fluosol-DA on cancer chemotherapeutic agents.
    Teicher BA; McIntosh-Lowe NL; Rose CM
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):533-46. PubMed ID: 2460166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.
    Teicher BA; Holden SA; Rose CM
    Int J Cancer; 1986 Aug; 38(2):285-8. PubMed ID: 3089945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo.
    Kim GE; Song CW
    Cancer Chemother Pharmacol; 1989; 25(2):99-102. PubMed ID: 2513138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.
    Teicher BA; Herman TS; Holden SA; Cathcart KN
    Cancer Chemother Pharmacol; 1988; 21(4):286-91. PubMed ID: 3131033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
    Teicher BA; Crawford JM; Holden SA; Cathcart KN
    Cancer Res; 1987 Oct; 47(19):5036-41. PubMed ID: 3113727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
    Moulder JE; Fish BL
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
    Teicher BA; Herman TS; Rose CM
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1187-92. PubMed ID: 3141321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas.
    Martin DF; Porter EA; Fischer JJ; Rockwell S
    Radiat Res; 1987 Oct; 112(1):45-53. PubMed ID: 3116598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.
    Tanaka J; Teicher BA; Herman TS; Holden SA; Dezube B; Frei E
    Int J Cancer; 1991 Jun; 48(4):631-7. PubMed ID: 2045206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents.
    Teicher BA; Holden SA
    Cancer Treat Rep; 1987 Feb; 71(2):173-7. PubMed ID: 3100035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
    Teicher BA; Holden SA; Northey D; Dewhirst MW; Herman TS
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):103-9. PubMed ID: 8482616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of scheduling, dose, and volume of administration of a perfluorochemical emulsion on tumor response to radiation therapy.
    Teicher BA; Herman TS; Jones SM
    Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):945-51. PubMed ID: 2211263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
    Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.